Linyan Meng,Mohan Pammi,Anirudh Saronwala,Pilar Magoulas,Andrew Ray Ghazi,Francesco Vetrini,Jing Zhang,Weimin He,Avinash V Dharmadhikari,Chunjing Qu,Patricia Ward,Alicia Braxton,Swetha Narayanan,Xiaoyan Ge,Mari J Tokita,Teresa Santiago-Sim,Hongzheng Dai,Theodore Chiang,Hadley Smith,Mahshid S Azamian,Laurie Robak,Bret L Bostwick,Christian P Schaaf,Lorraine Potocki,Fernando Scaglia,Carlos A Bacino,Neil A Hanchard,Michael F Wangler,Daryl Scott,Chester Brown,Jianhong Hu,John W Belmont,Lindsay C Burrage,Brett H Graham,Vernon Reid Sutton,William J Craigen,Sharon E Plon,James R Lupski,Arthur L Beaudet,Richard A Gibbs,Donna M Muzny,Marcus J Miller,Xia Wang,Magalie S Leduc,Rui Xiao,Pengfei Liu,Chad Shaw,Magdalena Walkiewicz,Weimin Bi,Fan Xia,Brendan Lee,Christine M Eng,Yaping Yang,Seema R Lalani

Abstract:IMPORTANCE While congenital malformations and genetic diseases are a leading cause of early infant death, to our knowledge, the contribution of single-gene disorders in this group is undetermined. OBJECTIVE To determine the diagnostic yield and use of clinical exome sequencing in critically ill infants. DESIGN, SETTING, AND PARTICIPANTS Clinical exome sequencing was performed for 278 unrelated infants within the first 100 days of life who were admitted to Texas Children's Hospital in Houston, Texas, during a 5-year period between December 2011 and January 2017. Exome sequencing types included proband exome, trio exome, and critical trio exome, a rapid genomic assay for seriously ill infants. MAIN OUTCOMES AND MEASURES Indications for testing, diagnostic yield of clinical exome sequencing, turnaround time, molecular findings, patient age at diagnosis, and effect on medical management among a group of critically ill infants who were suspected to have genetic disorders. RESULTS The mean (SEM) age for infants participating in the study was 28.5 (1.7) days; of these, the mean (SEM) age was 29.0 (2.2) days for infants undergoing proband exome sequencing, 31.5 (3.9) days for trio exome, and 22.7 (3.9) days for critical trio exome. Clinical indications for exome sequencing included a range of medical concerns. Overall, a molecular diagnosis was achieved in 102 infants (36.7%) by clinical exome sequencing, with relatively low yield for cardiovascular abnormalities. The diagnosis affected medical management for 53 infants (52.0%) and had a substantial effect on informed redirection of care, initiation of new subspecialist care, medication/dietary modifications, and furthering life-saving procedures in select patients. Critical trio exome sequencing revealed a molecular diagnosis in 32 of 63 infants (50.8%) at a mean (SEM) of 33.1 (5.6) days of life with a mean (SEM) turnaround time of 13.0 (0.4) days. Clinical care was altered by the diagnosis in 23 of 32 patients (71.9%). The diagnostic yield, patient age at diagnosis, and medical effect in the group that underwent critical trio exome sequencing were significantly different compared with the group who underwent regular exome testing. For deceased infants (n = 81), genetic disorders were molecularly diagnosed in 39 (48.1%) by exome sequencing, with implications for recurrence risk counseling. CONCLUSIONS AND RELEVANCE Exome sequencing is a powerful tool for the diagnostic evaluation of critically ill infants with suspected monogenic disorders in the neonatal and pediatric intensive care units and its use has a notable effect on clinical decision making.

Importance about use of high-throughput sequencing in pediatric: case report of a patient with Fanconi-Bickel syndrome

Fanconi-Bickel syndrome in an infant with cytomegalovirus infection: A case report and review of the literature

[Genetic and clinical analysis of a child with Shwachman-Diamond syndrome due to compound heterozygous variants of SBDS gene]

Diagnostic and Clinical Utility of Whole Genome Sequencing in a Cohort of Undiagnosed Chinese Families with Rare Diseases

Genetic, Clinical, and Biochemical Characterization of a Large Cohort of Palestinian Patients With Fanconi‐Bickel Syndrome

Case Report: Novel Biallelic Variants in DNAJC21 Causing an Inherited Bone Marrow Failure Spectrum Phenotype: An Odyssey to Diagnosis

Ultra-rare renal diseases diagnosed with whole-exome sequencing: Utility in diagnosis and management

De novo 11q13.3q13.4 deletion in a patient with Fanconi renotubular syndrome and intellectual disability: Case report and review of literature

Clinical report and genetic analysis of rare premature infant nephronophthisis caused by biallelic <i>TTC21B</i> variants

Role of next generation sequencing in diagnosis and management of critically ill children with suspected monogenic disorder

Use of Exome Sequencing for Infants in Intensive Care Units: Ascertainment of Severe Single-Gene Disorders and Effect on Medical Management.

Clinical Utility of Rapid Exome Sequencing Combined With Mitochondrial DNA Sequencing in Critically Ill Pediatric Patients With Suspected Genetic Disorders

Molecular Defects Identified by Whole Exome Sequencing in a Child with Atypical Mucopolysaccharidosis IIIB

Severe aldosterone synthase deficiency in a nine-day old Lebanese boy: the importance of functional studies to establish pathogenicity of seemingly benign variants in CYP11B2

Targeted Next-Generation Sequencing Panel for Clinical Diagnostic in Inherited Bone Marrow Failure Syndromes Benefit for Pediatric HSCT

[Molecular and Prenatal Diagnosis of a Family with Fanconi Anemia by Next Generation Sequencing].

Importance of genetic sequencing studies in managing chronic neonatal diarrhea: a case report of a novel variant in the glucose–galactose transporter SLC5A1

Case Report: A rare form of congenital erythrocytosis due to SLC30A10 biallelic variants—differential diagnosis and recommendation for biochemical and genetic screening

Advocating Targeted Sequential Screening over Whole Exome Sequencing in 21-Hydroxylase Deficiency

Clinical, genetic profile and therapy evaluation of 11 Chinese pediatric patients with Fanconi-Bickel syndrome

A Rare Inherited Bone Marrow Failure Syndrome Disclosed by Reanalysis of the Exome Data of a Patient Evaluated for Cytopenia and Dysmorphic Features